COMP <GO>
TFX vs UNH // REVENUE GROWTH (YOY)
Teleflex Incorporated (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: TFX 4
— UNH 10
▲ REVENUE GROWTH (YOY) LEADER: TFX
LAST: $140.67 (+0.64%) • MKT CAP: $5.96B
revenue-growth
17.20%
LAST: $400.44 (-1.60%) • MKT CAP: $359.43B
revenue-growth
3.33%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TFX VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TFX | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 56.20% | 88.31% | -32.11 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 1.80% | 12.38% | -10.58 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | 40.9x | 15.3x | +25.63 | UNH | /valuation <GO> |
| Free Cash Flow Yield | -18.00% | 6.25% | -24.25 | UNH | /fcf-yield <GO> |
| Operating Margin | 5.90% | 5.32% | +0.58 | TFX | /operating-margins <GO> |
| Net Profit Margin | -45.40% | 3.53% | -48.93 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 17.20% | 3.33% | +13.87 | TFX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.01% | 2.29% | -1.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.12 | 3.09 | -0.97 | UNH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 7/9 | -3.00 | UNH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 7.00% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 66.4 | 55.1 | +11.30 | TFX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.98 | 0.33 | +0.65 | TFX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 27.0x | 17.7x | +9.26 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.96B | $359.43B | -$353.47B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TFX REV | UNH REV | TFX GROSS % | UNH GROSS % | TFX FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.99B | $447.57B | 56.2% | 88.7% | — | $16.07B |
| FY 2024 | $1.70B | $400.28B | 61.0% | 88.3% | — | $20.70B |
| FY 2023 | $1.71B | $371.62B | — | 89.6% | — | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TFX // BETA 0.98
UNH // BETA 0.33